New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build

New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions

ValueSet: vaccine-code

Official URL: http://hl7.org/fhir/ValueSet/vaccine-code Version: 0.1.0
Draft as of 2024-11-11 Computable Name:

All codes for http://hl7.org/fhir/sid/cvx

References

Logical Definition (CLD)

Generated Narrative: ValueSet vaccine-code

 

Expansion

Generated Narrative: ValueSet vaccine-code

Expansion based on system Vaccine Administered Code Set (CVX) version20240514

This value set contains 273 concepts

CodeSystemDisplayDefinition
  143http://hl7.org/fhir/sid/cvxAdenovirus types 4 and 7

Adenovirus, type 4 and type 7, live, oral

  54http://hl7.org/fhir/sid/cvxadenovirus, type 4

adenovirus vaccine, type 4, live, oral

  55http://hl7.org/fhir/sid/cvxadenovirus, type 7

adenovirus vaccine, type 7, live, oral

  82http://hl7.org/fhir/sid/cvxadenovirus, unspecified formulation

adenovirus vaccine, unspecified formulation

  181http://hl7.org/fhir/sid/cvxanthrax immune globulin

anthrax immune globulin

  319http://hl7.org/fhir/sid/cvxAnthrax vaccine, unspecified

Anthrax vaccine, unspecified

  318http://hl7.org/fhir/sid/cvxAnthrax, post-exposure prophylaxis

Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis

  24http://hl7.org/fhir/sid/cvxAnthrax, pre-exposure prophylaxis, post-exposure prophylaxis

Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis

  801http://hl7.org/fhir/sid/cvxAS03 Adjuvant

AS03 Adjuvant

  19http://hl7.org/fhir/sid/cvxBCG

Bacillus Calmette-Guerin vaccine

  27http://hl7.org/fhir/sid/cvxbotulinum antitoxin

botulinum antitoxin

  317http://hl7.org/fhir/sid/cvxChikungunya live attenuated vaccine, 0.5 mL, PF

Chikungunya, live attenuated vaccine, 0.5 mL, preservative free

  173http://hl7.org/fhir/sid/cvxcholera, BivWC

cholera, BivWC

  174http://hl7.org/fhir/sid/cvxcholera, live attenuated

cholera, live attenuated

  26http://hl7.org/fhir/sid/cvxcholera, unspecified formulation

cholera vaccine, unspecified formulation

  172http://hl7.org/fhir/sid/cvxcholera, WC-rBS

cholera, WC-rBS

  29http://hl7.org/fhir/sid/cvxCMVIG

cytomegalovirus immune globulin, intravenous

  516http://hl7.org/fhir/sid/cvxCOV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)

SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)

  518http://hl7.org/fhir/sid/cvxCOVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)

SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)

  510http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (BIBP, Sinopharm)

SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm)

  511http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)

SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac)

  502http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (COVAXIN)

SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN)

  501http://hl7.org/fhir/sid/cvxCOVID-19 IV Non-US Vaccine (QAZCOVID-IN)

SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN)

  503http://hl7.org/fhir/sid/cvxCOVID-19 LAV Non-US Vaccine (COVIVAC)

SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC)

  519http://hl7.org/fhir/sid/cvxCOVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna

SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna

  520http://hl7.org/fhir/sid/cvxCOVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech

SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech

  500http://hl7.org/fhir/sid/cvxCOVID-19 Non-US Vaccine, Product Unknown

SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown

  507http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)

SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences)

  509http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (EpiVacCorona)

SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona)

  508http://hl7.org/fhir/sid/cvxCOVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)

SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention)

  521http://hl7.org/fhir/sid/cvxCOVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK

SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK

  212http://hl7.org/fhir/sid/cvxCOVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL

SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL

  210http://hl7.org/fhir/sid/cvxCOVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL

SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL

  506http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology

SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology

  504http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (Sputnik Light)

SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light)

  505http://hl7.org/fhir/sid/cvxCOVID-19 VVnr Non-US Vaccine (Sputnik V)

SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V)

  226http://hl7.org/fhir/sid/cvxCOVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL

SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose

  225http://hl7.org/fhir/sid/cvxCOVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL

SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose

  230http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose

  301http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation

  302http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation

  300http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation

  229http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose

  218http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation

  207http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose

  311http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose

  219http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation

  208http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose

  217http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation

  312http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose

  221http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose

  228http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose

  227http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose

  310http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose

  308http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose

  309http://hl7.org/fhir/sid/cvxCOVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL

SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose

  211http://hl7.org/fhir/sid/cvxCOVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL

SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose

  313http://hl7.org/fhir/sid/cvxCOVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL

SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose

  56http://hl7.org/fhir/sid/cvxdengue fever tetravalent

dengue fever vaccine, tetravalent

  12http://hl7.org/fhir/sid/cvxdiphtheria antitoxin

diphtheria antitoxin

  28http://hl7.org/fhir/sid/cvxDT (pediatric)

diphtheria and tetanus toxoids, adsorbed for pediatric use

  195http://hl7.org/fhir/sid/cvxDT, IPV adsorbed

Diphtheria, Tetanus, Poliomyelitis adsorbed

  20http://hl7.org/fhir/sid/cvxDTaP

diphtheria, tetanus toxoids and acellular pertussis vaccine

  106http://hl7.org/fhir/sid/cvxDTaP, 5 pertussis antigens

diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens

  107http://hl7.org/fhir/sid/cvxDTaP, unspecified formulation

diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation

  146http://hl7.org/fhir/sid/cvxDTaP,IPV,Hib,HepB

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.

  110http://hl7.org/fhir/sid/cvxDTaP-Hep B-IPV

DTaP-hepatitis B and poliovirus vaccine

  50http://hl7.org/fhir/sid/cvxDTaP-Hib

DTaP-Haemophilus influenzae type b conjugate vaccine

  120http://hl7.org/fhir/sid/cvxDTaP-Hib-IPV

diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)

  130http://hl7.org/fhir/sid/cvxDTaP-IPV

Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated

  132http://hl7.org/fhir/sid/cvxDTaP-IPV-HIB-HEP B, historical

Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.

  170http://hl7.org/fhir/sid/cvxDTAP/IPV/HIB - non-US

non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)

  1http://hl7.org/fhir/sid/cvxDTP

diphtheria, tetanus toxoids and pertussis vaccine

  198http://hl7.org/fhir/sid/cvxDTP-hepB-Hib Pentavalent Non-US

Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)

  22http://hl7.org/fhir/sid/cvxDTP-Hib

DTP-Haemophilus influenzae type b conjugate vaccine

  102http://hl7.org/fhir/sid/cvxDTP-Hib-Hep B

DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine

  204http://hl7.org/fhir/sid/cvxEbola Zaire vaccine, live, recombinant, 1mL dose

Ebola Zaire vaccine, live, recombinant, 1mL dose

  214http://hl7.org/fhir/sid/cvxEbola, unspecified

Ebola, unspecified

  57http://hl7.org/fhir/sid/cvxhantavirus

hantavirus vaccine

  30http://hl7.org/fhir/sid/cvxHBIG

hepatitis B immune globulin

  52http://hl7.org/fhir/sid/cvxHep A, adult

hepatitis A vaccine, adult dosage

  154http://hl7.org/fhir/sid/cvxHep A, IG

Hepatitis A immune globulin

  169http://hl7.org/fhir/sid/cvxHep A, live attenuated

Hep A, live attenuated-IM

  83http://hl7.org/fhir/sid/cvxHep A, ped/adol, 2 dose

hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule

  84http://hl7.org/fhir/sid/cvxHep A, ped/adol, 3 dose

hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule

  31http://hl7.org/fhir/sid/cvxHep A, pediatric, unspecified formulation

hepatitis A vaccine, pediatric dosage, unspecified formulation

  85http://hl7.org/fhir/sid/cvxHep A, unspecified formulation

hepatitis A vaccine, unspecified formulation

  104http://hl7.org/fhir/sid/cvxHep A-Hep B

hepatitis A and hepatitis B vaccine

  193http://hl7.org/fhir/sid/cvxHep A-Hep B, pediatric/adolescent

hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)

  8http://hl7.org/fhir/sid/cvxHep B, adolescent or pediatric

hepatitis B vaccine, pediatric or pediatric/adolescent dosage

  42http://hl7.org/fhir/sid/cvxHep B, adolescent/high risk infant

hepatitis B vaccine, adolescent/high risk infant dosage

  43http://hl7.org/fhir/sid/cvxHep B, adult

hepatitis B vaccine, adult dosage

  44http://hl7.org/fhir/sid/cvxHep B, dialysis

hepatitis B vaccine, dialysis patient dosage

  45http://hl7.org/fhir/sid/cvxHep B, unspecified formulation

hepatitis B vaccine, unspecified formulation

  58http://hl7.org/fhir/sid/cvxHep C

hepatitis C vaccine

  59http://hl7.org/fhir/sid/cvxHep E

hepatitis E vaccine

  220http://hl7.org/fhir/sid/cvxHepB recombinant, 3-antigen, Al(OH)3

Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted

  189http://hl7.org/fhir/sid/cvxHepB-CpG

Hepatitis B vaccine (recombinant), CpG adjuvanted

  60http://hl7.org/fhir/sid/cvxherpes simplex 2

herpes simplex virus, type 2 vaccine

  47http://hl7.org/fhir/sid/cvxHib (HbOC)

Haemophilus influenzae type b vaccine, HbOC conjugate

  46http://hl7.org/fhir/sid/cvxHib (PRP-D)

Haemophilus influenzae type b vaccine, PRP-D conjugate

  49http://hl7.org/fhir/sid/cvxHib (PRP-OMP)

Haemophilus influenzae type b vaccine, PRP-OMP conjugate

  48http://hl7.org/fhir/sid/cvxHib (PRP-T)

Haemophilus influenzae type b vaccine, PRP-T conjugate

  17http://hl7.org/fhir/sid/cvxHib, unspecified formulation

Haemophilus influenzae type b vaccine, conjugate unspecified formulation

  51http://hl7.org/fhir/sid/cvxHib-Hep B

Haemophilus influenzae type b conjugate and Hepatitis B vaccine

  61http://hl7.org/fhir/sid/cvxHIV

human immunodeficiency virus vaccine

  118http://hl7.org/fhir/sid/cvxHPV, bivalent

human papilloma virus vaccine, bivalent

  62http://hl7.org/fhir/sid/cvxHPV, quadrivalent

human papilloma virus vaccine, quadrivalent

  137http://hl7.org/fhir/sid/cvxHPV, unspecified formulation

HPV, unspecified formulation

  165http://hl7.org/fhir/sid/cvxHPV9

Human Papillomavirus 9-valent vaccine

  86http://hl7.org/fhir/sid/cvxIG

immune globulin, intramuscular

  14http://hl7.org/fhir/sid/cvxIG, unspecified formulation

immune globulin, unspecified formulation

  87http://hl7.org/fhir/sid/cvxIGIV

immune globulin, intravenous

  160http://hl7.org/fhir/sid/cvxInfluenza A monovalent (H5N1), ADJUVANTED-2013

Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013

  151http://hl7.org/fhir/sid/cvxinfluenza nasal, unspecified formulation

influenza nasal, unspecified formulation

  205http://hl7.org/fhir/sid/cvxInfluenza vaccine, quadrivalent, adjuvanted

influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free

  123http://hl7.org/fhir/sid/cvxinfluenza, H5N1-1203

influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)

  135http://hl7.org/fhir/sid/cvxInfluenza, high dose seasonal

influenza, high dose seasonal, preservative-free

  197http://hl7.org/fhir/sid/cvxinfluenza, high-dose, quadrivalent

influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free

  153http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, preservative free

Influenza, injectable, Madin Darby Canine Kidney, preservative free

  171http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, preservative free, quadrivalent

Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent

  186http://hl7.org/fhir/sid/cvxInfluenza, injectable, MDCK, quadrivalent, preservative

Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative

  158http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent

influenza, injectable, quadrivalent, contains preservative

  150http://hl7.org/fhir/sid/cvxinfluenza, injectable, quadrivalent, preservative free

Influenza, injectable, quadrivalent, preservative free

  161http://hl7.org/fhir/sid/cvxInfluenza, injectable,quadrivalent, preservative free, pediatric

Influenza, injectable,quadrivalent, preservative free, pediatric

  166http://hl7.org/fhir/sid/cvxinfluenza, intradermal, quadrivalent, preservative free

influenza, intradermal, quadrivalent, preservative free, injectable

  111http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal

influenza virus vaccine, live, attenuated, for intranasal use

  149http://hl7.org/fhir/sid/cvxinfluenza, live, intranasal, quadrivalent

influenza, live, intranasal, quadrivalent

  155http://hl7.org/fhir/sid/cvxinfluenza, recombinant, injectable, preservative free

Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free

  185http://hl7.org/fhir/sid/cvxinfluenza, recombinant, quadrivalent,injectable, preservative free

Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free

  141http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable

Influenza, seasonal, injectable

  140http://hl7.org/fhir/sid/cvxInfluenza, seasonal, injectable, preservative free

Influenza, seasonal, injectable, preservative free

  144http://hl7.org/fhir/sid/cvxinfluenza, seasonal, intradermal, preservative free

seasonal influenza, intradermal, preservative free

  194http://hl7.org/fhir/sid/cvxInfluenza, Southern Hemisphere

influenza, Southern Hemisphere, unspecified formulation

  231http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, high-dose, quadrivalent

influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free

  200http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, pediatric, preservative free

influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free

  201http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, preservative free

influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative

  202http://hl7.org/fhir/sid/cvxinfluenza, Southern Hemisphere, quadrivalent, with preservative

influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative

  15http://hl7.org/fhir/sid/cvxinfluenza, split (incl. purified surface antigen)

influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE

  168http://hl7.org/fhir/sid/cvxinfluenza, trivalent, adjuvanted

Seasonal trivalent influenza vaccine, adjuvanted, preservative free

  88http://hl7.org/fhir/sid/cvxinfluenza, unspecified formulation

influenza virus vaccine, unspecified formulation

  16http://hl7.org/fhir/sid/cvxinfluenza, whole

influenza virus vaccine, whole virus

  10http://hl7.org/fhir/sid/cvxIPV

poliovirus vaccine, inactivated

  134http://hl7.org/fhir/sid/cvxJapanese Encephalitis IM

Japanese Encephalitis vaccine for intramuscular administration

  39http://hl7.org/fhir/sid/cvxJapanese encephalitis SC

Japanese Encephalitis Vaccine SC

  129http://hl7.org/fhir/sid/cvxJapanese Encephalitis, unspecified formulation

Japanese Encephalitis vaccine, unspecified formulation

  63http://hl7.org/fhir/sid/cvxJunin virus

Junin virus vaccine

  64http://hl7.org/fhir/sid/cvxleishmaniasis

leishmaniasis vaccine

  65http://hl7.org/fhir/sid/cvxleprosy

leprosy vaccine

  66http://hl7.org/fhir/sid/cvxLyme disease

Lyme disease vaccine

  4http://hl7.org/fhir/sid/cvxM/R

measles and rubella virus vaccine

  67http://hl7.org/fhir/sid/cvxmalaria

malaria vaccine

  5http://hl7.org/fhir/sid/cvxmeasles

measles virus vaccine

  68http://hl7.org/fhir/sid/cvxmelanoma

melanoma vaccine

  191http://hl7.org/fhir/sid/cvxmeningococcal A polysaccharide (non-US)

meningococcal A polysaccharide vaccine (non-US)

  192http://hl7.org/fhir/sid/cvxmeningococcal AC polysaccharide (non-US)

meningococcal AC polysaccharide vaccine (non-US)

  108http://hl7.org/fhir/sid/cvxmeningococcal ACWY, unspecified formulation

meningococcal ACWY vaccine, unspecified formulation

  163http://hl7.org/fhir/sid/cvxmeningococcal B, OMV

meningococcal B vaccine, recombinant, OMV, adjuvanted

  162http://hl7.org/fhir/sid/cvxmeningococcal B, recombinant

meningococcal B vaccine, fully recombinant

  164http://hl7.org/fhir/sid/cvxmeningococcal B, unspecified

meningococcal B, unspecified formulation

  103http://hl7.org/fhir/sid/cvxmeningococcal C conjugate

meningococcal C conjugate vaccine

  148http://hl7.org/fhir/sid/cvxMeningococcal C/Y-HIB PRP

Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine

  203http://hl7.org/fhir/sid/cvxmeningococcal conjugate quadrivalent, MenACWY-TT (MCV4)

meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free

  147http://hl7.org/fhir/sid/cvxmeningococcal MCV4, unspecified formulation

Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)

  136http://hl7.org/fhir/sid/cvxMeningococcal MCV4O

meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)

  114http://hl7.org/fhir/sid/cvxmeningococcal MCV4P

meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)

  32http://hl7.org/fhir/sid/cvxmeningococcal MPSV4

meningococcal polysaccharide vaccine (MPSV4)

  316http://hl7.org/fhir/sid/cvxMeningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF

Meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free

  167http://hl7.org/fhir/sid/cvxmeningococcal, unknown serogroups

meningococcal vaccine of unknown formulation and unknown serogroups

  3http://hl7.org/fhir/sid/cvxMMR

measles, mumps and rubella virus vaccine

  94http://hl7.org/fhir/sid/cvxMMRV

measles, mumps, rubella, and varicella virus vaccine

  7http://hl7.org/fhir/sid/cvxmumps

mumps virus vaccine

  998http://hl7.org/fhir/sid/cvxno vaccine administered

no vaccine administered

  127http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09

Novel influenza-H1N1-09, injectable

  128http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, all formulations

Novel influenza-H1N1-09, all formulations

  125http://hl7.org/fhir/sid/cvxNovel Influenza-H1N1-09, nasal

Novel Influenza-H1N1-09, live virus for nasal administration

  126http://hl7.org/fhir/sid/cvxNovel influenza-H1N1-09, preservative-free

Novel influenza-H1N1-09, preservative-free, injectable

  2http://hl7.org/fhir/sid/cvxOPV

trivalent poliovirus vaccine, live, oral

  179http://hl7.org/fhir/sid/cvxOPV ,monovalent, unspecified

Non-US monovalent oral polio vaccine, unspecified formulation

  178http://hl7.org/fhir/sid/cvxOPV bivalent

Non-US bivalent oral polio vaccine (types 1 and 3)

  182http://hl7.org/fhir/sid/cvxOPV, Unspecified

Oral Polio Vaccine, Unspecified formulation

  69http://hl7.org/fhir/sid/cvxparainfluenza-3

parainfluenza-3 virus vaccine

  177http://hl7.org/fhir/sid/cvxPCV10

pneumococcal conjugate vaccine, 10 valent

  11http://hl7.org/fhir/sid/cvxpertussis

pertussis vaccine

  23http://hl7.org/fhir/sid/cvxplague

plague vaccine

  133http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV 13

pneumococcal conjugate vaccine, 13 valent

  100http://hl7.org/fhir/sid/cvxpneumococcal conjugate PCV 7

pneumococcal conjugate vaccine, 7 valent

  215http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF

Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free

  216http://hl7.org/fhir/sid/cvxPneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF

Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free

  152http://hl7.org/fhir/sid/cvxPneumococcal Conjugate, unspecified formulation

Pneumococcal Conjugate, unspecified formulation

  33http://hl7.org/fhir/sid/cvxpneumococcal polysaccharide PPV23

pneumococcal polysaccharide vaccine, 23 valent

  109http://hl7.org/fhir/sid/cvxpneumococcal, unspecified formulation

pneumococcal vaccine, unspecified formulation

  89http://hl7.org/fhir/sid/cvxpolio, unspecified formulation

poliovirus vaccine, unspecified formulation

  70http://hl7.org/fhir/sid/cvxQ fever

Q fever vaccine

  175http://hl7.org/fhir/sid/cvxRabies - IM Diploid cell culture

Human Rabies vaccine from human diploid cell culture

  176http://hl7.org/fhir/sid/cvxRabies - IM fibroblast culture

Human rabies vaccine from Chicken fibroblast culture

  40http://hl7.org/fhir/sid/cvxrabies, intradermal injection

rabies vaccine, for intradermal injection

  18http://hl7.org/fhir/sid/cvxrabies, intramuscular injection

rabies vaccine, for intramuscular injection RETIRED CODE

  90http://hl7.org/fhir/sid/cvxrabies, unspecified formulation

rabies vaccine, unspecified formulation

  99http://hl7.org/fhir/sid/cvxRESERVED - do not use

RESERVED - do not use

  315http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV) MAB, unspecified

Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified

  314http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV) vaccine, unspecified

Respiratory syncytial virus (RSV) vaccine, unspecified

  304http://hl7.org/fhir/sid/cvxRespiratory syncytial virus (RSV), unspecified

Respiratory syncytial virus (RSV), unspecified

  72http://hl7.org/fhir/sid/cvxrheumatic fever

rheumatic fever vaccine

  159http://hl7.org/fhir/sid/cvxRho(D) - Unspecified formulation

Rho(D) Unspecified formulation

  157http://hl7.org/fhir/sid/cvxRho(D) -IG IM

Rho(D) Immune globulin - IM

  156http://hl7.org/fhir/sid/cvxRho(D)-IG

Rho(D) Immune globulin- IV or IM

  73http://hl7.org/fhir/sid/cvxRift Valley fever

Rift Valley fever vaccine

  34http://hl7.org/fhir/sid/cvxRIG

rabies immune globulin

  119http://hl7.org/fhir/sid/cvxrotavirus, monovalent

rotavirus, live, monovalent vaccine

  116http://hl7.org/fhir/sid/cvxrotavirus, pentavalent

rotavirus, live, pentavalent vaccine

  74http://hl7.org/fhir/sid/cvxrotavirus, tetravalent

rotavirus, live, tetravalent vaccine

  122http://hl7.org/fhir/sid/cvxrotavirus, unspecified formulation

rotavirus vaccine, unspecified formulation

  305http://hl7.org/fhir/sid/cvxRSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF

Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free

  306http://hl7.org/fhir/sid/cvxRSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months

Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 0.5 mL, neonates and children to 24 months

  307http://hl7.org/fhir/sid/cvxRSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months

Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ, (nirsevimab-alip), 1 mL, neonates and children to 24 months

  303http://hl7.org/fhir/sid/cvxRSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF

Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free

  71http://hl7.org/fhir/sid/cvxRSV-IGIV

respiratory syncytial virus immune globulin, intravenous

  93http://hl7.org/fhir/sid/cvxRSV-MAb

respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular

  145http://hl7.org/fhir/sid/cvxRSV-MAb (new)

respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular

  6http://hl7.org/fhir/sid/cvxrubella

rubella virus vaccine

  38http://hl7.org/fhir/sid/cvxrubella/mumps

rubella and mumps virus vaccine

  213http://hl7.org/fhir/sid/cvxSARS-COV-2 (COVID-19) vaccine, UNSPECIFIED

SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED

  514http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)

SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D)

  513http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)

SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax)

  517http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)

SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax)

  515http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)

SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901)

  512http://hl7.org/fhir/sid/cvxSARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)

SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz)

  76http://hl7.org/fhir/sid/cvxStaphylococcus bacterio lysate

Staphylococcus bacteriophage lysate

  138http://hl7.org/fhir/sid/cvxTd (adult)

tetanus and diphtheria toxoids, not adsorbed, for adult use

  9http://hl7.org/fhir/sid/cvxTd (adult), 2 Lf tetanus toxoid, preservative free, adsorbed

tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)

  113http://hl7.org/fhir/sid/cvxTd (adult), 5 Lf tetanus toxoid, preservative free, adsorbed

tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)

  139http://hl7.org/fhir/sid/cvxTd(adult) unspecified formulation

Td(adult) unspecified formulation

  196http://hl7.org/fhir/sid/cvxTd, adsorbed, preservative free, adult use, Lf unspecified

tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified

  115http://hl7.org/fhir/sid/cvxTdap

tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed

  180http://hl7.org/fhir/sid/cvxtetanus immune globulin

tetanus immune globulin

  35http://hl7.org/fhir/sid/cvxtetanus toxoid, adsorbed

tetanus toxoid, adsorbed

  142http://hl7.org/fhir/sid/cvxtetanus toxoid, not adsorbed

tetanus toxoid, not adsorbed

  112http://hl7.org/fhir/sid/cvxtetanus toxoid, unspecified formulation

tetanus toxoid, unspecified formulation

  77http://hl7.org/fhir/sid/cvxTick-borne encephalitis vaccine (non-US)

Tick-borne encephalitis vaccine (non-US)

  223http://hl7.org/fhir/sid/cvxTick-borne encephalitis, inactivated, PF, 0.25mL

Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose

  224http://hl7.org/fhir/sid/cvxTick-borne encephalitis, inactivated, PF, 0.5mL

Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose

  222http://hl7.org/fhir/sid/cvxTick-borne encephalitis, unspecified

Tick-borne encephalitis vaccine, unspecified

  13http://hl7.org/fhir/sid/cvxTIG

tetanus immune globulin

  98http://hl7.org/fhir/sid/cvxTST, unspecified formulation

tuberculin skin test; unspecified formulation

  95http://hl7.org/fhir/sid/cvxTST-OT tine test

tuberculin skin test; old tuberculin, multipuncture device

  96http://hl7.org/fhir/sid/cvxTST-PPD intradermal

tuberculin skin test; purified protein derivative solution, intradermal

  97http://hl7.org/fhir/sid/cvxTST-PPD tine test

tuberculin skin test; purified protein derivative, multipuncture device

  78http://hl7.org/fhir/sid/cvxtularemia vaccine

tularemia vaccine

  190http://hl7.org/fhir/sid/cvxTyphoid conjugate vaccine (TCV)

Typhoid conjugate vaccine (non-US)

  25http://hl7.org/fhir/sid/cvxtyphoid, oral

typhoid vaccine, live, oral

  41http://hl7.org/fhir/sid/cvxtyphoid, parenteral

typhoid vaccine, parenteral, other than acetone-killed, dried

  53http://hl7.org/fhir/sid/cvxtyphoid, parenteral, AKD (U.S. military)

typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)

  91http://hl7.org/fhir/sid/cvxtyphoid, unspecified formulation

typhoid vaccine, unspecified formulation

  101http://hl7.org/fhir/sid/cvxtyphoid, ViCPs

typhoid Vi capsular polysaccharide vaccine

  131http://hl7.org/fhir/sid/cvxtyphus, historical

Historical record of a typhus vaccination

  999http://hl7.org/fhir/sid/cvxunknown

unknown vaccine or immune globulin

  75http://hl7.org/fhir/sid/cvxvaccinia (smallpox)

vaccinia (smallpox) vaccine

  105http://hl7.org/fhir/sid/cvxvaccinia (smallpox) diluted

vaccinia (smallpox) vaccine, diluted

  79http://hl7.org/fhir/sid/cvxvaccinia immune globulin

vaccinia immune globulin

  206http://hl7.org/fhir/sid/cvxVaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection

Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection

  21http://hl7.org/fhir/sid/cvxvaricella

varicella virus vaccine

  81http://hl7.org/fhir/sid/cvxVEE, inactivated

Venezuelan equine encephalitis, inactivated

  80http://hl7.org/fhir/sid/cvxVEE, live

Venezuelan equine encephalitis, live, attenuated

  92http://hl7.org/fhir/sid/cvxVEE, unspecified formulation

Venezuelan equine encephalitis vaccine, unspecified formulation

  36http://hl7.org/fhir/sid/cvxVZIG

varicella zoster immune globulin

  117http://hl7.org/fhir/sid/cvxVZIG (IND)

varicella zoster immune globulin (Investigational New Drug)

  37http://hl7.org/fhir/sid/cvxyellow fever live

yellow fever vaccine live

  183http://hl7.org/fhir/sid/cvxYellow fever vaccine live - alt

Yellow fever vaccine live - alternative formulation for vaccine shortage

  184http://hl7.org/fhir/sid/cvxYellow fever, unspecified

Yellow fever vaccine, unspecified formulation

  121http://hl7.org/fhir/sid/cvxzoster live

zoster vaccine, live

  187http://hl7.org/fhir/sid/cvxzoster recombinant

zoster vaccine recombinant

  188http://hl7.org/fhir/sid/cvxzoster, unspecified formulation

zoster vaccine, unspecified formulation


Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code